BIS UltraShort NASDAQ Biotechnology (2x) ETF

No holdings information is available in our database.

BIS UltraShort NASDAQ Biotechnology (2x) ETF

Seeks daily investment results before fees and expenses that correspond to twice (200%) the inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index. The Index contains securities of NASDAQ-listed companies, including ADRs of non-US companies, classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria.

$19.13  -0.40 (-2.05%)
As of 10/19/2021 16:00:00 EST     IEX book   CBOE book


ETF Information
Sponsor:     ProShares
Category1:  US Equity
Category2:  Single industry
Category3:  Biotechnology
Morningstar category:  Trading--Inverse Equity
Leverage factor:  -2.00
Inception date:  04/06/2010
Index tracking method: Passive replication
Current yield:  0.00%
Historical average yield:  0.02%
Market cap:  $7,735,833
Average volume:  9,776
Fees:     0.9500%

Index Information
NASDAQ Biotechnology Index
Index symbol:  NBI
Provider:   NASDAQ OMX
Index weighting:   Market capitalization
Index inception date:  11/01/1993
Backtesting data exists:   No
Number of holdings:  159  (as of 11/28/2017)

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy